A Safety Study to Investigate the Skin Sensitization Potential of MFC51123
Clinical trial NCT02192203 · COMPLETED
Trial details
- NCT number
- NCT02192203
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2014-07-15
- Enrollment
- 227
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.